Cargando…
Left Ventricular Systolic Function After 3 Months of SGLT2 Inhibitor Therapy in Heart Failure Patients with Reduced Ejection Fraction
Not much is known about the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on echocardiographic parameters of left ventricular (LV) systolic function in patients with heart failure and reduced ejection fraction (HFrEF). We prospectively included 59 outpatients with HFrEF: 41 patients...
Autores principales: | Mustapic, Ivona, Bakovic, Darija, Susilovic-Grabovac, Zora, Borovac, Josip Andjelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166024/ https://www.ncbi.nlm.nih.gov/pubmed/37155137 http://dx.doi.org/10.1007/s12265-023-10389-3 |
Ejemplares similares
-
Impact of SGLT2 Inhibitor Therapy on Right Ventricular Function in Patients with Heart Failure and Reduced Ejection Fraction
por: Mustapic, Ivona, et al.
Publicado: (2022) -
Right Ventricular Free Wall Strain and Congestive Hepatopathy in Patients with Acute Worsening of Chronic Heart Failure: A CATSTAT-HF Echo Substudy
por: Borovac, Josip A., et al.
Publicado: (2020) -
Association of inflammatory biomarkers and disease activity with subclinical myocardial dysfunction in psoriatic arthritis
por: Pletikosic, Ivan, et al.
Publicado: (2023) -
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study
por: Borovac, Josip A., et al.
Publicado: (2019) -
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT‐HF study
por: Borovac, Josip A., et al.
Publicado: (2020)